Zymeworks (ZYME) Research & Development (2021 - 2026)

Zymeworks (ZYME) has 6 years of Research & Development data on file, last reported at $34.5 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 3.58% year-over-year to $34.5 million; the trailing twelve-month figure through Mar 2026 stood at $135.7 million (down 1.88% YoY), and the FY2025 full-year result was $137.0 million, up 1.77% from the prior year.
• Research & Development advanced to $34.5 million in Q1 2026, from $31.2 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $62.5 million in Q1 2022 to a low of $25.5 million in Q4 2023.
• A 5-year average of $38.7 million and a median of $35.7 million in 2025 frame the typical range for Research & Development.
• Across the five-year window, Research & Development slumped 51.81% in 2023 and jumped 45.21% in 2024, its largest moves.
• Tracing ZYME's Research & Development over 5 years: stood at $53.0 million in 2022, then tumbled by 51.81% to $25.5 million in 2023, then jumped by 45.21% to $37.1 million in 2024, then retreated by 15.72% to $31.2 million in 2025, then increased by 10.32% to $34.5 million in 2026.
• Business Quant data shows ZYME's Research & Development at $34.5 million in Q1 2026, $31.2 million in Q4 2025, and $35.6 million in Q3 2025.